Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Newer antidepressants and panic disorder: a meta-analysis.

Andrisano C, Chiesa A, Serretti A.

Int Clin Psychopharmacol. 2013 Jan;28(1):33-45. doi: 10.1097/YIC.0b013e32835a5d2e. Review.

PMID:
23111544
2.

A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.

Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M.

Clin Neuropharmacol. 2007 Nov-Dec;30(6):326-34.

PMID:
18090457
3.

Current pharmacological interventions in panic disorder.

Freire RC, Machado S, Arias-Carrión O, Nardi AE.

CNS Neurol Disord Drug Targets. 2014;13(6):1057-65. Review.

PMID:
24923349
4.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
5.

The use of newer antidepressants for panic disorder.

Gorman JM.

J Clin Psychiatry. 1997;58 Suppl 14:54-8; discussion 59. Review.

PMID:
9418747
6.

A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.

Perna G, Bertani A, Caldirola D, Smeraldi E, Bellodi L.

Pharmacopsychiatry. 2001 May;34(3):85-90.

PMID:
11434404
8.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
9.

Sertraline treatment of panic disorder: response in patients at risk for poor outcome.

Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R.

J Clin Psychiatry. 2000 Dec;61(12):922-7.

PMID:
11206597
10.

Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.

Hirschmann S, Dannon PN, Iancu I, Dolberg OT, Zohar J, Grunhaus L.

J Clin Psychopharmacol. 2000 Oct;20(5):556-9.

PMID:
11001241
11.

Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.

Mochcovitch MD, Nardi AE.

Expert Rev Neurother. 2010 Aug;10(8):1285-93. doi: 10.1586/ern.10.110. Review.

PMID:
20662754
12.

Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia.

Bakker A, van Balkom AJ, van Dyck R.

Int Clin Psychopharmacol. 2000 Aug;15 Suppl 2:S25-30. Review.

PMID:
11110016
13.

Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.

Asnis GM, Hameedi FA, Goddard AW, Potkin SG, Black D, Jameel M, Desagani K, Woods SW.

Psychiatry Res. 2001 Aug 5;103(1):1-14.

PMID:
11472786
14.

Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.

Nair NP, Bakish D, Saxena B, Amin M, Schwartz G, West TE.

Anxiety. 1996;2(4):192-8.

PMID:
9160622
16.

[Panic disorder and agoraphobia: what is effective?].

Bandelow B, Sievert K, Röthemeyer M, Hajak G, Broocks A, Rüther E.

Fortschr Neurol Psychiatr. 1995 Nov;63(11):451-64. Review. German.

PMID:
8575719
17.

A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants.

Toni C, Perugi G, Frare F, Mata B, Vitale B, Mengali F, Recchia M, Serra G, Akiskal HS.

Pharmacopsychiatry. 2000 Jul;33(4):121-31.

PMID:
10958260
18.

Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.

Versiani M, Cassano G, Perugi G, Benedetti A, Mastalli L, Nardi A, Savino M.

J Clin Psychiatry. 2002 Jan;63(1):31-7.

PMID:
11838623
19.

Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder.

Palatnik A, Frolov K, Fux M, Benjamin J.

J Clin Psychopharmacol. 2001 Jun;21(3):335-9.

PMID:
11386498
20.

Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.

Thase ME, Nierenberg AA, Vrijland P, van Oers HJ, Schutte AJ, Simmons JH.

Int Clin Psychopharmacol. 2010 Jul;25(4):189-98. doi: 10.1097/YIC.0b013e328330adb2.

PMID:
20531012

Supplemental Content

Support Center